References
  1. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J.2015;36:3075–3128.
  2. Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, et al. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA.2011;306:2239–2247.
  3. Thuny F, Beurtheret S, Mancini J, Gariboldi V, Casalta JP, Riberi A, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J. 2011;32:2027–2033.
  4. Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante-Mangoni A, et al. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med.2013;173:1495–1504.
  5. Olmos C, Vilacosta I, Fernández C, Lopez J, Sarria C, Ferrera C, et al. Contemporary epidemiology and prognosis of septic shock in infective endocarditis. Eur Heart J. 2013;34:1999–2006.
  6. García-Cabrera E, Fernández-Hidalgo N, Almirante B, Ivanova- Georgieva R, Noureddine M, Plata A, et al. Neurological complications of infective endocarditis risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation.2013;127:2272–2284.
  7. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012;366:2466–2473.
  8. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017; 70: 252–289.
  9. Wang D, Wang Q, Yang X, Wu Q, Li Q. Mitral valve replacement through a minimal right vertical infra-axillary thoracotomy versus standard median sternotomy. Ann Thorac Surg. 2009;87:704–708.
  10. Aklog L, Adams DH, Couper GS, Gobezie R, Sears S, Cohn LH. Techniques and results of direct-access minimally invasive mitral valve surgery: a paradigm for the future. J Thorac Cardiovasc Surg.1998;116:705–715.
  11. Glower DD, Landolfo KP, Clements F, Debruijn NP, Stafford-Smith M, Smith PK, et al. Mitral valve operation via Port Access versus median sternotomy. Eur J Cardiothorac Surg. 1998;14(Suppl 1):S143–S147.
  12. Suri RM, Antiel RM, Burkhart HM, Huebner M, Li Z, Eton DT, et al. Quality of life after early mitral valve repair using conventional and robotic approaches. Ann Thorac Surg. 2012;93:761–769.
  13. Hill EE, Herijgers P, Claus P, Vanderschueren S, Peetermans WE, Herregods MC. Abscess in infective endocarditis: the value of transesophageal echocardiography and outcome: a 5-year study. Am Heart J. 2007;154:923–928.
  14. Habib G, Badano L, Tribouilloy C, Vilacosta I, Zamorano JL. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr. 2010;11:202–219.
  15. Ansari A, Rigolin VH. Infective endocarditis: an update on the role of echocardiography. Curr Cardiol Rep. 2010;12:265–271.